Universal Influenza Vaccine Update

Published Online: Monday, January 28, 2013
Follow Pharmacy_Times:
In this video, recorded at ICAAC 2012, the American Society for Microbiology’s annual infectious diseases meeting, Jeff Fox, PhD, features editor of Microbe, talks with Donna Ambrosino and Zachary Shriver of Visterra Inc about efforts to develop a universal influenza vaccine that will be capable of protecting against any potential strain of the influenza virus. Currently, the influenza vaccine must be updated annually to protect against the strains of influenza expected to circulate in a given year, leaving people vulnerable to novel virus strains.

Related Articles
Certain flu virus subtypes have more potential to cause severe illness than others, according to a new study published in mBio. For that reason, avian influenza viruses that express the more dangerous subtypes should be monitored closely to prevent the spread of severe disease.
The FDA has expanded its approval of Protein Sciences Corp’s Flublok influenza vaccine to cover patients aged 50 years and older, thus permitting its use in all adults.
Latest Issues
$auto_registration$